Skip to main content
NASDAQ:CLVS

Clovis Oncology News Headlines

$5.71
+0.10 (+1.78 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.45
$6.07
50-Day Range
$5.29
$7.47
52-Week Range
$4.08
$11.10
Volume3.83 million shs
Average Volume10.94 million shs
Market Capitalization$597.07 million
P/E RatioN/A
Dividend YieldN/A
Beta2.1

Headlines

Clovis Oncology (NASDAQ CLVS) News Headlines Today

SourceHeadline
Clovis Oncology (NASDAQ:CLVS) Trading 7.7% Higher Clovis Oncology (NASDAQ:CLVS) Trading 7.7% Higher
americanbankingnews.com - May 12 at 1:38 PM
Clovis Oncology (NASDAQ:CLVS) PT Lowered to $12.00 at HC WainwrightClovis Oncology (NASDAQ:CLVS) PT Lowered to $12.00 at HC Wainwright
americanbankingnews.com - May 11 at 10:44 AM
Clovis Oncology (NASDAQ:CLVS) Expected to Earn Q2 2021 Earnings of ($0.55) Per ShareClovis Oncology (NASDAQ:CLVS) Expected to Earn Q2 2021 Earnings of ($0.55) Per Share
americanbankingnews.com - May 10 at 2:34 AM
Piper Sandler Weighs in on Clovis Oncologys Q2 2021 Earnings (NASDAQ:CLVS)Piper Sandler Weighs in on Clovis Oncology's Q2 2021 Earnings (NASDAQ:CLVS)
americanbankingnews.com - May 10 at 2:34 AM
Clovis Oncology: Another Upcycle ComingClovis Oncology: Another Upcycle Coming
seekingalpha.com - May 8 at 1:31 PM
If You Had Bought Clovis Oncologys (NASDAQ:CLVS) Shares Three Years Ago You Would Be Down 88%If You Had Bought Clovis Oncology's (NASDAQ:CLVS) Shares Three Years Ago You Would Be Down 88%
finance.yahoo.com - May 7 at 1:01 PM
Clovis Oncology (NASDAQ:CLVS) Issues  Earnings Results, Beats Expectations By $0.08 EPSClovis Oncology (NASDAQ:CLVS) Issues Earnings Results, Beats Expectations By $0.08 EPS
americanbankingnews.com - May 6 at 10:04 PM
Clovis (CLVS) Q1 Earnings Beat, COVID-19 Hurts Rubraca SalesClovis (CLVS) Q1 Earnings Beat, COVID-19 Hurts Rubraca Sales
finance.yahoo.com - May 6 at 11:56 AM
Clovis Oncology Reports 11% Drop In Q1 Sales As COVID-19 Hit Rubraca SalesClovis Oncology Reports 11% Drop In Q1 Sales As COVID-19 Hit Rubraca Sales
finance.yahoo.com - May 5 at 5:29 PM
HC Wainwright Lowers Clovis Oncology (NASDAQ:CLVS) Price Target to $12.00HC Wainwright Lowers Clovis Oncology (NASDAQ:CLVS) Price Target to $12.00
americanbankingnews.com - May 5 at 1:56 PM
What Is Going On With Clovis Oncology Today?What Is Going On With Clovis Oncology Today?
markets.businessinsider.com - May 5 at 12:29 PM
Clovis Oncology Announces First Quarter 2021 Operating ResultsClovis Oncology Announces First Quarter 2021 Operating Results
finance.yahoo.com - May 5 at 12:29 PM
Clovis Oncology (CLVS) Reports Q1 Loss, Misses Revenue EstimatesClovis Oncology (CLVS) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 5 at 12:29 PM
Clovis Oncology (NASDAQ:CLVS) Shares Gap Down to $5.51Clovis Oncology (NASDAQ:CLVS) Shares Gap Down to $5.51
americanbankingnews.com - May 5 at 12:02 PM
Gillian C. Ivers-Read Sells 3,952 Shares of Clovis Oncology (NASDAQ:CLVS) StockGillian C. Ivers-Read Sells 3,952 Shares of Clovis Oncology (NASDAQ:CLVS) Stock
americanbankingnews.com - May 5 at 4:36 AM
Clovis Oncology to Present at the Bank of America 2021 Health Care ConferenceClovis Oncology to Present at the Bank of America 2021 Health Care Conference
finance.yahoo.com - April 28 at 6:45 PM
Clovis Oncology (CLVS) Scheduled to Post Quarterly Earnings on WednesdayClovis Oncology (CLVS) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - April 28 at 6:46 AM
$44.84 Million in Sales Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter$44.84 Million in Sales Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter
americanbankingnews.com - April 27 at 3:32 AM
 Analysts Anticipate Clovis Oncology (NASDAQ:CLVS) Will Announce Earnings of -$0.72 Per Share Analysts Anticipate Clovis Oncology (NASDAQ:CLVS) Will Announce Earnings of -$0.72 Per Share
americanbankingnews.com - April 25 at 8:50 AM
-$0.72 Earnings Per Share Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter-$0.72 Earnings Per Share Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter
americanbankingnews.com - April 25 at 8:16 AM
Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5
finance.yahoo.com - April 21 at 8:34 PM
Clovis Oncology: Your Keys To Banking ProfitsClovis Oncology: Your Keys To Banking Profits
seekingalpha.com - April 13 at 5:20 AM
What Is The Ownership Structure Like For Clovis Oncology, Inc. (NASDAQ:CLVS)?What Is The Ownership Structure Like For Clovis Oncology, Inc. (NASDAQ:CLVS)?
nasdaq.com - April 12 at 6:29 PM
Clovis Oncologys Rubraca shows promise for prostate cancer in phase 1 trialClovis Oncology's Rubraca shows promise for prostate cancer in phase 1 trial
seekingalpha.com - April 11 at 10:28 AM
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021
finance.yahoo.com - April 10 at 8:40 AM
Why Is Clovis (CLVS) Up 4.4% Since Last Earnings Report?Why Is Clovis (CLVS) Up 4.4% Since Last Earnings Report?
finance.yahoo.com - March 25 at 3:58 PM
Could Clovis Oncology (CLVS) shares be the next GameStop?Could Clovis Oncology (CLVS) shares be the next GameStop?
uk.finance.yahoo.com - March 24 at 9:00 AM
Clovis (CLVS) Stock Jumps 47.7%: Will It Continue to Soar?Clovis (CLVS) Stock Jumps 47.7%: Will It Continue to Soar?
nasdaq.com - March 22 at 10:24 AM
Thinking about buying stock in SuperCom, Clovis Oncology, Mogo Inc, Evolus, or Infinity Pharmaceuticals?Thinking about buying stock in SuperCom, Clovis Oncology, Mogo Inc, Evolus, or Infinity Pharmaceuticals?
marketwatch.com - March 21 at 12:30 AM
Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA ...Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA ...
businesswire.com - March 20 at 9:30 AM
Why Clovis Oncology Stock Skyrocketed TodayWhy Clovis Oncology Stock Skyrocketed Today
fool.com - March 19 at 4:37 PM
Clovis Oncology Stock Rallies: Technical Levels To WatchClovis Oncology Stock Rallies: Technical Levels To Watch
feeds.benzinga.com - March 19 at 2:16 PM
Why Clovis Oncology, Marker Therapeutics, Alector Are Rallying FridayWhy Clovis Oncology, Marker Therapeutics, Alector Are Rallying Friday
markets.businessinsider.com - March 19 at 1:32 PM
Clovis Oncology Skyrockets on Ovarian Cancer Drug SuccessClovis Oncology Skyrockets on Ovarian Cancer Drug Success
msn.com - March 19 at 1:32 PM
Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA MutationClovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation
finance.yahoo.com - March 19 at 8:32 AM
Clovis Oncology stock soars after ovarian cancer treatment meets primary endpointClovis Oncology stock soars after ovarian cancer treatment meets primary endpoint
finance.yahoo.com - March 19 at 8:32 AM
CLVS Apr 2021 2.000 callCLVS Apr 2021 2.000 call
uk.finance.yahoo.com - March 17 at 8:55 AM
CLVS Mar 2021 1.000 callCLVS Mar 2021 1.000 call
sg.finance.yahoo.com - March 16 at 8:00 AM
Understanding Clovis Oncologys Unusual Options ActivityUnderstanding Clovis Oncology's Unusual Options Activity
finance.yahoo.com - March 2 at 5:13 PM
Thinking about buying stock in Workhorse Group, Sundial Growers, Nokia, Clovis Oncology, or Compugen?Thinking about buying stock in Workhorse Group, Sundial Growers, Nokia, Clovis Oncology, or Compugen?
marketwatch.com - February 25 at 12:55 PM
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q4 2020 Results - Earnings Call TranscriptClovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 24 at 7:33 PM
Clovis Oncology: Q4 Earnings InsightsClovis Oncology: Q4 Earnings Insights
finance.yahoo.com - February 23 at 4:56 PM
Clovis (CLVS) Q4 Earnings Miss, Revenues Beat, Stock DownClovis (CLVS) Q4 Earnings Miss, Revenues Beat, Stock Down
nasdaq.com - February 23 at 11:56 AM
Clovis Oncology Announces 2020 Operating ResultsClovis Oncology Announces 2020 Operating Results
finance.yahoo.com - February 23 at 11:55 AM
Clovis Oncology, Inc. to Host Earnings CallClovis Oncology, Inc. to Host Earnings Call
finance.yahoo.com - February 23 at 6:55 AM
Earnings Preview for Clovis OncologyEarnings Preview for Clovis Oncology
finance.yahoo.com - February 22 at 5:47 PM
Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23
finance.yahoo.com - February 17 at 12:56 PM
CLVS Feb 2021 11.000 putCLVS Feb 2021 11.000 put
sg.finance.yahoo.com - February 12 at 7:43 PM
Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual MeetingClovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting
finance.yahoo.com - February 11 at 8:32 AM
Could The Clovis Oncology, Inc. (NASDAQ:CLVS) Ownership Structure Tell Us Something Useful?Could The Clovis Oncology, Inc. (NASDAQ:CLVS) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 6 at 9:49 AM
This page was last updated on 5/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.